304 related articles for article (PubMed ID: 23937685)
1. Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy.
Leung E; Warde P; Jewett M; Panzarella T; O'Malley M; Sweet J; Moore M; Sturgeon J; Gospodarowicz M; Chung P
BJU Int; 2013 Dec; 112(8):1088-95. PubMed ID: 23937685
[TBL] [Abstract][Full Text] [Related]
2. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
[TBL] [Abstract][Full Text] [Related]
3. Barriers to the implementation of surveillance for stage I testicular seminoma.
Arvold ND; Catalano PJ; Sweeney CJ; Hoffman KE; Nguyen PL; Balboni TA; Fosså SD; Travis LB; Beard CJ
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):383-9. PubMed ID: 22349043
[TBL] [Abstract][Full Text] [Related]
4. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
5. Management of stage I testicular seminoma.
Mok G; Warde P
Hematol Oncol Clin North Am; 2011 Jun; 25(3):503-16, vii-iii. PubMed ID: 21570605
[TBL] [Abstract][Full Text] [Related]
6. Management of stage II seminoma.
Warde P; Gospodarowicz M; Panzarella T; Catton C; Sturgeon J; Moore M; Jewett M
J Clin Oncol; 1998 Jan; 16(1):290-4. PubMed ID: 9440755
[TBL] [Abstract][Full Text] [Related]
7. Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: a surveillance, epidemiology, and end results (SEER) analysis.
Jones G; Arthurs B; Kaya H; Macdonald K; Qin R; Fairbanks RK; Lamoreaux WT; Jawed I; Tward JD; Martincic D; Shivnani AT; Lee CM
Am J Clin Oncol; 2013 Oct; 36(5):500-4. PubMed ID: 22781383
[TBL] [Abstract][Full Text] [Related]
8. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy.
Mistretta FA; Mazzone E; Palumbo C; Knipper S; Tian Z; Nazzani S; Lattouf JB; Musi G; Perrotte P; Montanari E; Shariat SF; Montorsi F; Saad F; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2019 Aug; 17(4):e793-e801. PubMed ID: 31182339
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic options following orchiectomy for stage I seminoma.
Lawrentschuk N; Fleshner NE
Oncology (Williston Park); 2009 Aug; 23(9):749-53. PubMed ID: 19777758
[TBL] [Abstract][Full Text] [Related]
11. Surveillance in stage I testicular seminoma.
Chung P; Warde P
Urol Oncol; 2006; 24(1):75-9. PubMed ID: 16414499
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results.
De Felice F; Musio D; Gravina GL; Marampon F; Tombolini V
Oncotarget; 2016 Nov; 7(48):80077-80082. PubMed ID: 27556300
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.
Oliver RT; Mason MD; Mead GM; von der Maase H; Rustin GJ; Joffe JK; de Wit R; Aass N; Graham JD; Coleman R; Kirk SJ; Stenning SP;
Lancet; 2005 Jul 23-29; 366(9482):293-300. PubMed ID: 16039331
[TBL] [Abstract][Full Text] [Related]
14. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.
Hallemeier CL; Pisansky TM; Davis BJ; Choo R
Urol Oncol; 2013 Nov; 31(8):1832-8. PubMed ID: 22537538
[TBL] [Abstract][Full Text] [Related]
16. Excellent long-term disease control with modern radiotherapy techniques for stage I testicular seminoma--the Mayo Clinic experience.
Hallemeier CL; Choo R; Davis BJ; Leibovich BC; Costello BA; Pisansky TM
Urol Oncol; 2014 Jan; 32(1):24.e1-6. PubMed ID: 23490907
[TBL] [Abstract][Full Text] [Related]
17. Surveillance in stage I seminoma patients: a long-term assessment.
Cummins S; Yau T; Huddart R; Dearnaley D; Horwich A
Eur Urol; 2010 Apr; 57(4):673-8. PubMed ID: 19545941
[TBL] [Abstract][Full Text] [Related]
18. Treatment of stage I seminoma: a 15-year review.
Alomary I; Samant R; Gallant V
Urol Oncol; 2006; 24(3):180-3. PubMed ID: 16678046
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma.
Choo R; Thomas G; Woo T; Lee D; Kong B; Iscoe N; Danjoux C; Klotz L; Morton G; Chander S
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):736-40. PubMed ID: 15708251
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
